Findings

What do systematic reviews say?

4,720 questions · 15,377 findings · 900 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 3,865 · 25.1%GRADE not reported 2,291 · 14.9%Very low 3,875 · 25.2%Low 3,287 · 21.4%Moderate 1,681 · 10.9%High 378 · 2.5%

Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.

Intervention not reported

Adverse event: number of people who were re‐admitted · adults following hip fracture surgery

The intervention showed no clear difference in adverse event: number of people who were re‐admitted (low certainty).

1 finding from 1 review

Interventions for improving mobility after hip fracture surgery in adults 2022 · Cochrane Headline outcomes only
RR 0.7 [0.44, 1.11]
4 studies · 322 participants
Low

Intervention not reported

Number of people who returned to living at pre‐fracture residence · adults following hip fracture surgery

The intervention showed no clear difference in number of people who returned to living at pre‐fracture residence (low certainty).

1 finding from 1 review

Interventions for improving mobility after hip fracture surgery in adults 2022 · Cochrane Headline outcomes only
RR 1.07 [0.73, 1.56]
2 studies · 240 participants
Low

Intervention not reported

Mobility outcome · adults following hip fracture surgery

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for improving mobility after hip fracture surgery in adults 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Mobility scales, using different mobility scales: MILA (range 0 to 36), EMS (range 0 to 20), BBS (range 0 to 56), PPME (range 0 to 12), Koval (range 1 to 7). Higher values indicate better mobility (except MILA and Koval, where scale was inverted f... · adults following hip fracture surgery

The intervention probably leads to higher mobility scales, using different mobility scales: MILA (range 0 to… (moderate certainty).

1 finding from 1 review

Interventions for improving mobility after hip fracture surgery in adults 2022 · Cochrane Headline outcomes only
SMD 0.57 [0.07, 1.06]
6 studies · 463 participants
Moderate

Summary of findings table ‐ Pseudophakia vs aphakia

Visual acuity · children younger than two years of age with bilateral congenital cataracts

1 finding from 1 review

Surgical interventions for bilateral congenital cataract in children aged two years and under 2022 · Cochrane Headline outcomes only
no estimate extracted
1 study · 54 participants
Very low

Summary of findings table ‐ Pseudophakia vs aphakia

Visual axis opacification · children younger than two years of age with bilateral congenital cataracts

It is very uncertain whether summary of findings table ‐ Pseudophakia changes visual axis opacification compared with aphakia (very low certainty).

1 finding from 1 review

Surgical interventions for bilateral congenital cataract in children aged two years and under 2022 · Cochrane Headline outcomes only
RR 1.29 [0.23, 7.13]
1 study · 54 participants
Very low

Summary of findings table ‐ Pseudophakia vs aphakia

Amblyopia ‐ not reported · children younger than two years of age with bilateral congenital cataracts

The review found no eligible studies for this question.

1 finding from 1 review

Surgical interventions for bilateral congenital cataract in children aged two years and under 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings table ‐ Pseudophakia vs aphakia

Glaucoma at 5 years · children younger than two years of age with bilateral congenital cataracts

It is very uncertain whether summary of findings table ‐ Pseudophakia changes glaucoma at 5 years compared with aphakia (very low certainty).

1 finding from 1 review

Surgical interventions for bilateral congenital cataract in children aged two years and under 2022 · Cochrane Headline outcomes only
RR 0.86 [0.24, 3.1]
1 study · 54 participants
Very low

Summary of findings table ‐ Pseudophakia vs aphakia

Retinal detachment ‐ not reported · children younger than two years of age with bilateral congenital cataracts

The review found no eligible studies for this question.

1 finding from 1 review

Surgical interventions for bilateral congenital cataract in children aged two years and under 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings table ‐ Pseudophakia vs aphakia

Reoperation rate ‐ not reported · children younger than two years of age with bilateral congenital cataracts

The review found no eligible studies for this question.

1 finding from 1 review

Surgical interventions for bilateral congenital cataract in children aged two years and under 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings table ‐ Pseudophakia vs aphakia

Adverse events · children younger than two years of age with bilateral congenital cataracts

1 finding from 1 review

Surgical interventions for bilateral congenital cataract in children aged two years and under 2022 · Cochrane Headline outcomes only
no estimate extracted
1 study · 54 participants
Very low

Cyclosporin vs different comparators

Complete remission of proteinuria · adults with FSGS

Cyclosporin may leads to higher complete remission of proteinuria compared with different comparators (low certainty).

1 finding from 1 review

Interventions for focal segmental glomerulosclerosis in adults 2022 · Cochrane Headline outcomes only
RR 2.31 [1.13, 4.73]
4 studies · 231 participants
Low

Cyclosporin vs different comparators

Partial remission of proteinuria · adults with FSGS

Cyclosporin showed no clear difference in partial remission of proteinuria compared with different comparators (low certainty).

1 finding from 1 review

Interventions for focal segmental glomerulosclerosis in adults 2022 · Cochrane Headline outcomes only
RR 1.36 [0.78, 2.39]
4 studies · 231 participants
Low

Cyclosporin vs different comparators

Complete or partial remission · adults with FSGS

Cyclosporin may leads to higher complete or partial remission compared with different comparators (low certainty).

1 finding from 1 review

Interventions for focal segmental glomerulosclerosis in adults 2022 · Cochrane Headline outcomes only
RR 1.64 [1.1, 2.44]
4 studies · 231 participants
Low

Cyclosporin vs different comparators

Chronic kidney disease · adults with FSGS

Cyclosporin showed no clear difference in chronic kidney disease compared with different comparators (low certainty).

1 finding from 1 review

Interventions for focal segmental glomerulosclerosis in adults 2022 · Cochrane Headline outcomes only
RR 0.83 [0.35, 1.96]
4 studies · 231 participants
Low

Cyclosporin vs different comparators

Kidney failure · adults with FSGS

Cyclosporin showed no clear difference in kidney failure compared with different comparators (low certainty).

1 finding from 1 review

Interventions for focal segmental glomerulosclerosis in adults 2022 · Cochrane Headline outcomes only
RR 0.55 [0.15, 2]
4 studies · 231 participants
Low

Cyclosporin vs different comparators

Adverse events: hypertension · adults with FSGS

1 finding from 1 review

Interventions for focal segmental glomerulosclerosis in adults 2022 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 187 participants
Very low

Cyclosporin vs different comparators

Adverse effects: infection · adults with FSGS

1 finding from 1 review

Interventions for focal segmental glomerulosclerosis in adults 2022 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 157 participants
Low

Low molecular weight heparin vs no prophylaxis

PE: assessed by CT arteriography ( · adults undergoing KA

Low‐molecular‐weight heparin showed no clear difference in PE: assessed by CT arteriography ( compared with no prophylaxis (moderate certainty).

1 finding from 1 review

Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy 2022 · Cochrane Headline outcomes only
RR 1.81 [0.49, 6.65]
3 studies · 1820 participants
Moderate

Low molecular weight heparin vs no prophylaxis

Symptomatic DVT · adults undergoing KA

Low‐molecular‐weight heparin showed no clear difference in symptomatic DVT: assessed by presence of symptoms and confirmed by a… compared with no prophylaxis (low certainty).

1 finding from 1 review

Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy 2022 · Cochrane Headline outcomes only
RR 0.61 [0.18, 2.03]
4 studies · 1848 participants
Low